Off-Label Use of Atypical AntipsychoticsCause for Concern?

被引：0
|
作者：
Andrew McKean
Erik Monasterio
机构：
[1] The Princess Margaret Hospital,Pharmacy Department
[2] Hillmorton Hospital,Medlicott Academic Unit
来源：
CNS Drugs | 2012年 / 26卷
关键词：
Major Depressive Disorder; Anxiety Disorder; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Licensed indications for medicines were designed to regulate the claims that can be made about a medicine by a pharmaceutical company. Off-label prescribing (i.e. prescribing a drug for an indication outside of that for which it is licensed) is legal and an integral part of medical practice. In psychiatry, off-label prescribing is common and gives clinicians scope to treat patients who are refractory to standard therapy or where there is no licensed medication for an indication. However, efficacy or safety of such off-label use may not be established.
引用
收藏
页码：383 / 390
页数：7
相关论文
共 50 条
  • [31] Off-Label Use Reimbursement
    Cohen, Joshua
    Wilson, Andrew
    Faden, Laura
    FOOD AND DRUG LAW JOURNAL, 2009, 64 (02) : 391 - 403
  • [32] DexamethasoneCataract and off-label use
    Reactions Weekly, 2024, 2008 (1) : 128 - 128
  • [33] A Hemorrhage of Off-Label Use
    Karkouti, Keyvan
    Levy, Jerrold H.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (05) : 339 - 339
  • [34] QUETIAPINE OFF-LABEL USE
    Levin, R.
    Cosmatos, I
    Dieck, G.
    Reifsnyder, J.
    VALUE IN HEALTH, 2016, 19 (07) : A522 - A522
  • [35] Methylphenidate Off-label Use
    Trenque, T.
    DRUG SAFETY, 2012, 35 (10) : 891 - 891
  • [36] Off-label use of vaccines
    Neels, Pieter
    Southern, James
    Abramson, Jon
    Duclos, Philippe
    Hombach, Joachim
    Marti, Melanie
    Fitzgerald-Husek, Alanna
    Fournier-Caruana, Jacqueline
    Hanquet, Germaine
    VACCINE, 2017, 35 (18) : 2329 - 2337
  • [37] Off-label use in neurology
    Diener, HC
    AKTUELLE NEUROLOGIE, 2002, 29 (08) : 379 - 381
  • [38] A Hemorrhage of Off-Label Use
    Avorn, Jerry
    Kesselheim, Aaron
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 566 - 567
  • [39] Off-label use of infliximab
    Onder, M.
    Salavastru, C.
    Fritz, K.
    HAUTARZT, 2013, 64 (10): : 757 - 761
  • [40] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
12345